Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Metabolism: Clinical and Experimental
|
November 15, 2011
The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort
Danijela Gasevic, Jiri Frohlich, G B John Mancini, et al.
Diabetes Care
|
March 5, 2002
Hypertriglyceridemic hyperapoB in type 2 diabetes
Allan D Sniderman, Benoit Lamarche, Jessica Tilley, et al.
Lipids in Health and Disease
|
June 20, 2015
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
Ramesh Saeedi, Kevin Johns, Jiri Frohlich, et al.
Journal of Lipid Research
|
January 13, 2011
Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography
Milada Dobiásová, Jiri Frohlich, Michaela Sedová, et al.
Sultan Qaboos University Medical Journal
|
December 23, 2016
Statin-Associated Muscle Adverse Events: Update for clinicians
Maha A Al-Mohaissen, Martha J Ignaszewski, Jiri Frohlich, et al.
Lipids in Health and Disease
|
September 13, 2011
Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study
Supna Sandhu, Ahmad Al-Sarraf, Catalin Taraboanta, et al.
The Canadian Journal of Cardiology
|
September 30, 2014
Implementing phytosterols into medical practice as a cholesterol-lowering strategy: overview of efficacy, effectiveness, and safety
Suhad S AbuMweis, Christopher P F Marinangeli, Jiri Frohlich, et al.
Lipids
|
December 8, 2005
Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues
William E Connor, Don S Lin, Anuradha S Pappu, et al.
Atherosclerosis
|
August 24, 2007
Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia
Helena Vaverkova, David Karasek, Dalibor Novotny, et al.
Clinical Biochemistry
|
March 19, 2013
Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjects
Helena Vaverkova, David Karasek, Dalibor Novotny, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Metabolism: Clinical and Experimental
|
November 15, 2011
The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort
Danijela Gasevic, Jiri Frohlich, G B John Mancini, et al.
Diabetes Care
|
March 5, 2002
Hypertriglyceridemic hyperapoB in type 2 diabetes
Allan D Sniderman, Benoit Lamarche, Jessica Tilley, et al.
Lipids in Health and Disease
|
June 20, 2015
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
Ramesh Saeedi, Kevin Johns, Jiri Frohlich, et al.
Journal of Lipid Research
|
January 13, 2011
Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography
Milada Dobiásová, Jiri Frohlich, Michaela Sedová, et al.
Sultan Qaboos University Medical Journal
|
December 23, 2016
Statin-Associated Muscle Adverse Events: Update for clinicians
Maha A Al-Mohaissen, Martha J Ignaszewski, Jiri Frohlich, et al.
Lipids in Health and Disease
|
September 13, 2011
Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study
Supna Sandhu, Ahmad Al-Sarraf, Catalin Taraboanta, et al.
The Canadian Journal of Cardiology
|
September 30, 2014
Implementing phytosterols into medical practice as a cholesterol-lowering strategy: overview of efficacy, effectiveness, and safety
Suhad S AbuMweis, Christopher P F Marinangeli, Jiri Frohlich, et al.
Lipids
|
December 8, 2005
Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues
William E Connor, Don S Lin, Anuradha S Pappu, et al.
Atherosclerosis
|
August 24, 2007
Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia
Helena Vaverkova, David Karasek, Dalibor Novotny, et al.
Clinical Biochemistry
|
March 19, 2013
Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjects
Helena Vaverkova, David Karasek, Dalibor Novotny, et al.
Page
of 8